CONEXEU SCIENCES INC.

Ajouter à une liste

Communiqués Conexeu Sciences Inc.

Actions

CNXU

US20715F1003

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 24/07/2026			Varia. 5j.	Varia. 1 janv.
8,570 ^USD	-6,34%		-12,82%	-

14/07	Conexeu Sciences détaille la conclusion de l'étude préclinique P.R.O.O.F. de 12 mois pour sa plateforme CXU	CI
07/07	Conexeu Sciences achève l'étude préclinique P.R.O.O.F sur 12 mois pour sa plateforme CXU et annonce son intention de pénétrer le marché de la médecine esthétique	CI

Communiqués

15/07	The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.	AQ
15/07	A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next	AQ
14/07	The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It	AQ
09/07	One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics	AQ
07/07	A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It	AQ
07/07	A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill	AQ
01/07	A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity	AQ
29/06	Conexeu Sciences : Initial Statement of Beneficial Ownership (Form 3)	PU
25/06	The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It	AQ
25/06	Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform	AQ
16/06	Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower	AQ
15/06	Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing	AQ
09/06	A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus	AQ
08/06	Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program	AQ
03/06	Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026	AQ
27/05	UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine	AQ
27/05	After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead	AQ
21/05	Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"	NE

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Espace mes listes

Palmarès

Suite du Palmarès

Palmarès

Suite du Palmarès

Devises / Forex

Matières Premières

Cryptomonnaies

Taux d'Intérêts

Tous les transcripts sur plus de 9000 sociétés, le jour de leur publication !

Débloquez-les Maintenant !

Débloquez-les Maintenant !